Adamas Pharmaceuticals reported 150.64M in Assets for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acadia Pharmaceuticals ACAD:US $ 724.43M 30.74M
Acorda Therapeutics ACOR:US $ 491.5M 92.55M
Adamas Pharmaceuticals ADMS:US 150.64M 18.6M
Aerie Pharmaceuticals AERI:US $ 355.53M 7.2M
Aptinyx Inc APTX:US $ 134.17M 18.72M
Biocryst Pharmaceuticals BCRX:US $ 277.28M 7.15M
Flexion Therapeutics FLXN:US $ 210.05M 20.33M
Glaxosmithkline GSK:US $ 77011M 1068M
GlaxoSmithKline GSK:LN 77011M 1068M
Gw Pharmaceuticals GWPH:US $ 934.34M 5.17M
Heron Therapeutics HRTX:US $ 404.25M 93.32M
Intra Cellular Therapies ITCI:US $ 625.7M 48.79M
Marinus Pharmaceuticals MRNS:US $ 124.99M 8.87M
Neurocrine Biosciences NBIX:US $ 1956.4M 110M
Novartis NOVN:VX SF 124015M 2263M
Omeros OMER:US $ 145.39M 16.05M
Prothena PRTA:US $ 436.38M 56.66M
Revance Therapeutics RVNC:US $ 640.88M 35.07M
Teva Pharmaceutical TEVA:IT 49.2B 191M
Zogenix ZGNX:US $ 540.07M 40.89M